Trial intelligence / Profile preview

Pitavastatin versus atorvastatin in primary hypercholesterolemia or combined dyslipidemia

2005-001000-39Phase 3Completed

Sponsor
Kowa Research Europe
Start
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pitavastatin and atorvastatin in hypercholesterolemia and combined dyslipidaemia (4 arms), sponsored by Kowa Research Europe. Primary endpoint: LDL cholesterol reduction non-inferiority. Started Mar 2006; status: completed.

02

Drugs

pitavastatinatorvastatin
03

Conditions

hypercholesterolemiacombined dyslipidaemia

Beyond the preview

Go deeper on 2005-001000-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001000-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call